CLINICAL_TRIALS ClinicalTrials.gov record update

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05801705
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:09.830325+00:00
Published At: 2023-05-18T00:00:00+00:00
Record Updated At: 2023-05-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hormone-receptor-positive Breast Cancer", "Premenopausal Breast Cancer", "Breast Cancer Patients at Intermediate to High Risk", "Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or Torimefen"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-05-18"
protocolSection.identificationModule.nctId: "NCT05801705"
protocolSection.identificationModule.officialTitle: "Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.